ARTICLE | Clinical News
Corifollitropin alfa regulatory update
August 18, 2014 7:00 AM UTC
Merck disclosed in its 2Q14 financial results that FDA issued a complete response letter for corifollitropin alfa for controlled ovarian stimulation to treat infertility in women participating in assi...